Inspira Tech Bags Israeli Regulatory Nod for Cardiopulmonary Bypass

Inspira Technologies, an innovative medical technology firm, has revealed that the INSPIRA ART100, an extracorporeal membrane oxygenation and cardiopulmonary bypass system, has been granted approval by the Israeli Ministry of Health for medical devices and accessories (AMAR).

This showcases a pivotal achievement for Inspira's plan to engage in business development efforts in order to introduce its groundbreaking products and technologies to the market. Inspira Technologies sees obtaining Israeli regulatory approval for the INSPIRA ART100 as a key milestone in building local backing and usage, showcasing their proficiency in securing regulatory clearances for their products.

Dr. Dekel Stavi, head of the Israeli Extra-Corporeal Membrane Oxygenation (ECMO) Society and Inspira's Medical Director, commented, "As a physician and the head of the Israeli ECMO Society, I am delighted to witness this exciting milestone where hospitals will have the opportunity to acquire and use the innovative and technologically cutting-edge INSPIRA ART100."

Dagi Ben-Noon, CEO of Inspira Technologies, stated, "After we received FDA approval for the INSPIRA ART100 that will allow us to establish our presence in the US, receiving AMAR approval will facilitate the creation of business opportunities in new regions and emerging markets."

The medical technology firm aims to transform the landscape of respiratory and life-support technologies. We are working on innovative life support technologies and strategies to extend and enhance the lives of patients. Inspira aims to be the top innovative medical device company in our industry, forging alliances globally.